Patents Assigned to S.I.S. Shulov Innovative Science Ltd.
  • PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES
    Publication number: 20220387547
    Abstract: Pharmaceutical compositions comprising specific tetrapeptides, for use in reducing the release or inhibiting the activity of inflammatory cytokines and mediator and treatment of diseases and disorders associated with these cytokines and mediators.
    Type: Application
    Filed: August 8, 2022
    Publication date: December 8, 2022
    Applicant: S.I.S. SHULOV INNOVATIVE SCIENCE LTD.
    Inventor: Naftali PRIMOR
  • Pharmaceutical compositions for inhibiting inflammatory cytokines
    Patent number: 11419913
    Abstract: Pharmaceutical compositions comprising specific tetrapeptides, for use in reducing the release or inhibiting the activity of inflammatory cytokines and mediator and treatment of diseases and disorders associated with these cytokines and mediators.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: August 23, 2022
    Assignee: S.I.S SHULOV INNOVATIVE SCIENCE LTD.
    Inventor: Naftali Primor
  • Method for treating disorders of the skin
    Patent number: 9012397
    Abstract: A topical pharmaceutical composition for treating a skin disorder selected from the group consisting of Herpes viral infection, Varicella viral infection, rash, insect bites, jellyfish stings, burns, psoriasis, itching, skin allergic response, skin lesions as a result of drug or medical treatment side effects or complications, and hypopigmantation. The composition comprises a peptide of the formula pGLU—X—Y—Z, where X, Y and Z are amino acids, with or without an alkyl group, and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: March 25, 2012
    Date of Patent: April 21, 2015
    Assignee: S.I.S. Shulov Innovative Science Ltd.
    Inventor: Naftali Primor
  • METHOD FOR TREATING DISORDERS OF THE SKIN
    Publication number: 20130310309
    Abstract: A topical pharmaceutical composition for treating a skin disorder selected from the group consisting of Herpes viral infection, Varicella viral infection, rash, insect bites, jellyfish stings, burns, psoriasis, itching, skin allergic response, skin lesions as a result of drug or medical treatment side effects or complications, and hypopigmantation. The composition comprises a peptide of the formula pGLU-X—Y—Z, where X, Y and Z are amino acids, with or without an alkyl group, and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: March 25, 2012
    Publication date: November 21, 2013
    Applicant: S.I.S. Shulov Innovative Science Ltd.
    Inventor: Naftali Primor